Page last updated: 2024-08-22

vidarabine and Di Guglielmo Disease

vidarabine has been researched along with Di Guglielmo Disease in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, JC; Ishiguro, K; Lin, TS; Sartorelli, AC1
Bandieri, E; Forghieri, F; Luppi, M; Maccaferri, M; Morselli, M; Potenza, L; Torelli, G; Volzone, F1
Fathi, AT; Hasserjian, R; Sadrzadeh, H1
Callet Bauchu, E; Dumontet, C; Fabianowska-Majewska, K; Fang, X; Gandhi, V; Gazzo, S; Lepoivre, M; MacKey, J; Mantincic, D; Peters, GJ; Rolland, MO; Tigaud, I; Vanier-Viornery, A; Voorn, DA; Wyczechowska, D1
Bown, N; Hamilton, PJ; Jackson, GH; Reid, MM; Taylor, PR; Wells, AW1

Other Studies

5 other study(ies) available for vidarabine and Di Guglielmo Disease

ArticleYear
Purine and 8-substituted purine arabinofuranosyl and ribofuranosyl nucleoside derivatives as potential inducers of the differentiation of the Friend erythroleukemia.
    Journal of medicinal chemistry, 1985, Volume: 28, Issue:10

    Topics: Animals; Antimetabolites; Arabinonucleosides; Cell Differentiation; Cell Division; Cell Line; Chemical Phenomena; Chemistry; Friend murine leukemia virus; Hematopoiesis; Leukemia, Erythroblastic, Acute; Mice; Purine Nucleosides; Ribonucleosides; Structure-Activity Relationship

1985
Persistent hiccups as an adverse event to FLAG-IDA regimen for leukemia.
    Acta oncologica (Stockholm, Sweden), 2009, Volume: 48, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Filgrastim; Granulocyte Colony-Stimulating Factor; Hiccup; Humans; Idarubicin; Leukemia, Erythroblastic, Acute; Male; Middle Aged; Recombinant Proteins; Remission Induction; Vidarabine

2009
Pure erythroid leukemia evolving from a therapy-related myelodysplastic syndrome secondary to treatment for chronic lymphocytic leukemia.
    American journal of hematology, 2013, Volume: 88, Issue:3

    Topics: Abnormal Karyotype; Aged; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cyclophosphamide; Fatal Outcome; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Myelodysplastic Syndromes; Prednisone; Vidarabine; Vincristine

2013
Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562.
    British journal of haematology, 1999, Volume: 106, Issue:1

    Topics: Antineoplastic Agents; Cladribine; Cytarabine; Deoxycytidine; Deoxycytidine Kinase; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Gemcitabine; Humans; K562 Cells; Leukemia, Erythroblastic, Acute; Phenotype; Vidarabine

1999
Erythroleukaemia in the north of England: a population based study.
    Journal of clinical pathology, 2001, Volume: 54, Issue:8

    Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cytarabine; Cytogenetics; Daunorubicin; England; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Incidence; Leukemia, Erythroblastic, Acute; Male; Middle Aged; Prospective Studies; Risk; Survival Rate; Thioguanine; Treatment Outcome; Vidarabine

2001